 |
|
|
|
 |
|
Table 1
|
|
Correlation between NY-ESO-1 mRNA expression and pathological and clinical features in advanced prostate cancer.
|
Pathological and Clinical Features
|
NY-ESO-1 mRNA Positive Tumors
|
|
Proportion
|
Percentage
|
|
Benign prostatic hyperplasia
|
0/8
|
0%
|
|
All tumor specimens
|
20/53
|
38%
|
|
Gleason's
score
|
less than or equal to
7
|
6/21
|
29%
|
|
greater than or equal to 8
|
14/32
|
44%
|
|
Clinical stage
|
C
|
4/15
|
27%
|
|
D1
|
1/3
|
33%
|
|
D2
|
15/35
|
43%
|
|
|
|
|
|
|
Copyright
© 2003 by Yuji Noguchi